TY - JOUR
T1 - Global hospital-based disease management of acute diverticulitis
T2 - a prospective, international cohort study
AU - DAMASCUS Collaborati9ve
AU - Sami, A. Lawgaly
AU - Fatma, A. Monib
AU - Muhammad, Aakif
AU - Hazim, Ababneh
AU - Malak, Ababneh
AU - Mourtada, Abakar
AU - Hamdy, Abd elhady
AU - Mohamed, Abdel Aziz
AU - Mai, Abdelbaset
AU - Mohamed, Abdel Maboud
AU - Mohamed, Abdel Maboud
AU - Mina Ragaa Fekry, Abdelmalak
AU - Sherief, Abd elsalam
AU - Abdurrahman, Abdelzaher
AU - Yasser, Abdul Aal
AU - Eman, Abdulwahed
AU - Roberta, Abete
AU - Amira, Abo Ali
AU - Khadega, Abotaleb
AU - Nagm Eldin, Abu Elnaga
AU - Amer, Abu Hmaid
AU - Abu Ismail, Dima Y.
AU - Dema, Abu mahfouz
AU - Duaa, Abu nawas
AU - Hala, Abu Selmiyh
AU - Luai, Abu Ismail
AU - Amro, Abuleil
AU - Abwini, Mahmoud S.
AU - Shivanie, Acharya
AU - Lina, Acosta
AU - Alexis, Adam
AU - Katie, Adams
AU - Clare, Adams
AU - Samuel, Adegbola
AU - Bin Jabr Ala'a, Adel Jabr
AU - Yasmine, Adel Mohammed
AU - Ademola, Adeyeye
AU - Rebecca, Adeyeye
AU - Alfred, Adiamah
AU - Mohamed, Adwi
AU - Emma, Afify
AU - Mohamed, Afzal
AU - Shahrukh, Ahmad
AU - Bisan, Ahmad
AU - Rawan, Ahmed
AU - Rizwan, Ahmed
AU - Nauman, Ahmed
AU - Jamil, Ahmed
AU - Irele-Ifijeh, Ahonkhai
AU - Onur, Guven
N1 - Publisher Copyright:
© 2025 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license. http://creativecommons.org/licenses/by/4.0/
PY - 2025/11
Y1 - 2025/11
N2 - Background: Acute diverticulitis is a common condition that can be a surgical emergency. Its prevalence is increasing worldwide, however optimal management remains unclear. This study aimed to determine current practice and short-term outcomes globally. Methods: A prospective, international cohort study of patients presenting with acute diverticulitis to secondary care units was undertaken. Countries were stratified by geographical region and income groups. Patients presenting over a 44-week recruitment period (1/10/2020–31/8/2021) were included. Patient and disease covariates, management and short-term outcomes were captured in a secure web application. The primary outcome of interest was the geographical variation in presentation and treatment. The secondary outcome was treatment success at 30-days. Findings: 6189 patients presenting with acute diverticulitis (confirmed by CT imaging and/or surgical findings) were recruited. 2798 of 6189 patients presented with uncomplicated disease of whom 849 (30.3%) were treated in an ambulatory manner. Overall antibiotic use ranged across geographical regions from 1838 of 1982 patients (92.7%) to 340 of 342 patients (99.4%). Surgical intervention was undertaken in 782 of 6189 patients (12.6%) varying between geographical regions from 29 of 342 patients (8.8%) to 59 of 195 patients (42.8%). 675 of 782 patients underwent resection, of whom 180 (26.6%) underwent formation of a primary anastomosis. 707 of 6189 (11%) patients experienced treatment failure, with an overall 30-day mortality of 2.8% (169/6189 patients). 30-day mortality was higher in patients with complicated disease (142/3391 patients, 4.5%) and in low-middle income units (20/335 patients, 6.2%). Interpretation: This large, global study reveals significant variation in the management and outcomes of patients presenting to hospital with acute diverticulitis. Antibiotic use and hospital admission for uncomplicated disease was high, and significant variation in stoma formation was observed. Patients presenting in low-middle income units were more likely to undergo emergency surgery and this was associated with a higher 30-day mortality rate. Funding: Bowel Research UK.
AB - Background: Acute diverticulitis is a common condition that can be a surgical emergency. Its prevalence is increasing worldwide, however optimal management remains unclear. This study aimed to determine current practice and short-term outcomes globally. Methods: A prospective, international cohort study of patients presenting with acute diverticulitis to secondary care units was undertaken. Countries were stratified by geographical region and income groups. Patients presenting over a 44-week recruitment period (1/10/2020–31/8/2021) were included. Patient and disease covariates, management and short-term outcomes were captured in a secure web application. The primary outcome of interest was the geographical variation in presentation and treatment. The secondary outcome was treatment success at 30-days. Findings: 6189 patients presenting with acute diverticulitis (confirmed by CT imaging and/or surgical findings) were recruited. 2798 of 6189 patients presented with uncomplicated disease of whom 849 (30.3%) were treated in an ambulatory manner. Overall antibiotic use ranged across geographical regions from 1838 of 1982 patients (92.7%) to 340 of 342 patients (99.4%). Surgical intervention was undertaken in 782 of 6189 patients (12.6%) varying between geographical regions from 29 of 342 patients (8.8%) to 59 of 195 patients (42.8%). 675 of 782 patients underwent resection, of whom 180 (26.6%) underwent formation of a primary anastomosis. 707 of 6189 (11%) patients experienced treatment failure, with an overall 30-day mortality of 2.8% (169/6189 patients). 30-day mortality was higher in patients with complicated disease (142/3391 patients, 4.5%) and in low-middle income units (20/335 patients, 6.2%). Interpretation: This large, global study reveals significant variation in the management and outcomes of patients presenting to hospital with acute diverticulitis. Antibiotic use and hospital admission for uncomplicated disease was high, and significant variation in stoma formation was observed. Patients presenting in low-middle income units were more likely to undergo emergency surgery and this was associated with a higher 30-day mortality rate. Funding: Bowel Research UK.
KW - Acute diverticulitis
KW - Ambulatory care
KW - Antibiotics
KW - Computed tomography
KW - Surgery
UR - https://www.scopus.com/pages/publications/105017892644
U2 - 10.1016/j.eclinm.2025.103548
DO - 10.1016/j.eclinm.2025.103548
M3 - Article
AN - SCOPUS:105017892644
SN - 2589-5370
VL - 89
JO - eClinicalMedicine
JF - eClinicalMedicine
M1 - 103548
ER -